With patent litigation down 13% over 2013, and median damages awards just $2.9 million, the lowest in at least 20 years, NPEs are still besting
With patent litigation down 13% over 2013, and median damages awards just $2.9 million, the lowest in at least 20 years, NPEs are still besting
It is unclear that companies with the most significant increases in R&D spending are securing more, better quality or valuable patents. A random study of
The Supreme Court’s decision in Alice Corporation v. CLS Bank International, a case involving computer software, has led to a marked increase in patents being invalidated
Despite a soft first quarter 2015 for the 13 IP licensing company stocks that comprise the PIPX IP Stock Index, versus the S&P 500, individual
There is a great deal of agreement that patent quality is lacking, but surprisingly little about how to define and achieve it. Patent quality is
The goal of the USPTO gathering is to promote discussion of ways to improve patent quality. The first Patent Quality Summit will take place at
Not everyone agrees that another round of patent reform is necessary at this time. Doubters believe that the Innovation Act, H.R. 9 in its current form, will
The comment that follows is from Life360 CEO Chris Hulls in response to the 2/9/15 IP CloseUp post, “Family App Developer Says it’s the Victim
When it comes to invention rights (patents) it is often difficult to determine who is a victim and who is merely promoting its agenda. Life360,
More than half of Google and Microsoft’s 2014 US patent grants were in methods-related classes. IBM and Apple also were active filers in these areas.
Size helped in 2014 when it came to public IP licensing company stock performance, but it did not assure success. As a group, the twelve
More than one-third of the IP CloseUp® 30 public patent licensing companies (or PIPCOs) are currently selling for less than or about $1 per share —